UROGENITAL CANCER
Clinical trials for UROGENITAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL CANCER trials appear
Sign up with your email to follow new studies for UROGENITAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests two experimental drugs, bintrafusp alfa and PDS01ADC, alone or with targeted radiation, in adults with metastatic bladder, kidney, or other non-prostate genitourinary cancers. The goal is to see if the combination is safe and helps the immune system f…
Matched conditions: UROGENITAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:41 UTC
-
Immune drug atezolizumab tested before surgery for rare urinary cancers
Disease control Recruiting nowThis study tests whether the drug atezolizumab can shrink tumors in people with certain types of urothelial cancer before they have surgery. About 58 adults will receive two doses of the drug, which helps the immune system attack cancer cells. After treatment, they will have stan…
Matched conditions: UROGENITAL CANCER
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Scientists launch Largest-Ever Watch-and-Learn study for rare urinary cancers
Knowledge-focused Recruiting nowThis study tracks 1,100 adults with common and rare urinary tract cancers (like bladder, kidney, or testicular cancer) over their lifetime. Researchers collect medical records, blood, urine, and tumor samples to understand how these cancers behave and respond to treatment. The go…
Matched conditions: UROGENITAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 11:35 UTC